Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Mar 31:2013:812718.
doi: 10.1155/2013/812718. Print 2013.

Collagen scaffolds in bone sialoprotein-mediated bone regeneration

Thomas E Kruger  1 , Andrew H Miller, Jinxi Wang
Affiliations
Review

Collagen scaffolds in bone sialoprotein-mediated bone regeneration

Thomas E Kruger et al. ScientificWorldJournal. .

Abstract

Decades of research in bioengineering have resulted in the development of many types of 3-dimentional (3D) scaffolds for use as drug delivery systems (DDS) and for tissue regeneration. Scaffolds may be comprised of different natural fibers and synthetic polymers as well as ceramics in order to exert the most beneficial attributes including biocompatibility, biodegradability, structural integrity, cell infiltration and attachment, and neovascularization. Type I collagen scaffolds meet most of these criteria. In addition, type I collagen binds integrins through RGD and non-RGD sites which facilitates cell migration, attachment, and proliferation. Type I collagen scaffolds can be used for bone tissue repair when they are coated with osteogenic proteins such as bone morphogenic protein (BMP) and bone sialoprotein (BSP). BSP, a small integrin-binding ligand N-linked glycoprotein (SIBLING), has osteogenic properties and plays an essential role in bone formation. BSP also mediates mineral deposition, binds type I collagen with high affinity, and binds α v β 3 and α v β 5 integrins which mediate cell signaling. This paper reviews the emerging evidence demonstrating the efficacy of BSP-collagen scaffolds in bone regeneration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The process of type I collagen synthesis. (a) Two identical α1(I) and one α2(I) peptide chains self-assemble to form procollagen (b). (c) Procollagen peptidase removes loose termini to create a type I tropocollagen molecule (d). Tropocollagen molecules self-assemble to form a growing collagen fibril (e). Self-assembly of collagen fibrils forms a type I collagen fiber (f).
Figure 2
Figure 2
BSP-collagen implant preparation and implantation. A diagram shows the process of BSP-collagen implant preparation, BSP-collagen implantation into a rat calvarial bone defect and new bone formation in the defect at day 30 after implantation of BSP-collagen.
See this image and copyright information in PMC

References

    1. Di Lullo GA, Sweeney SM, Körkkö J, Ala-Kokko L, San Antonio JD. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. The Journal of Biological Chemistry. 2002;277(6):4223–4231. - PubMed
    1. Kadler KE, Baldock C, Bella J, Boot-Handford RP. Collagens at a glance. Journal of Cell Science. 2007;120, part 12:1955–1958. - PubMed
    1. Veit G, Kobbe B, Keene DR, Paulsson M, Koch M, Wagener R. Collagen XXVIII, a novel von Willebrand factor A domain-containing protein with many imperfections in the collagenous domain. The Journal of Biological Chemistry. 2006;281(6):3494–3504. - PubMed
    1. Gelse K, Pöschl E, Aigner T. Collagens—structure, function, and biosynthesis. Advanced Drug Delivery Reviews. 2003;55(12):1531–1546. - PubMed
    1. Huang S, Fu X. Naturally derived materials-based cell and drug delivery systems in skin regeneration. Journal of Controlled Release. 2010;142(2):149–159. - PubMed

Publication types